Bristol Myers Squibb (BMY) Requires $252,000 for $10,000 Income
Published on · Source: finance.yahoo.com

AI Summary
Summarized by AI from the source belowTo generate $10,000 annually from Bristol Myers Squibb (BMY), an investor would need approximately 3,968 shares and a capital investment of about $252,000 at the current dividend yield of 3.94%. Eliquis, one of BMY's key drugs, may face a revenue decline between $1.5 billion and $2 billion in 2027 due to a patent expiration in April 2028. Meanwhile, BMY's Growth Portfolio now accounts for nearly 60% of its revenue, which grew 14%. With the stock having increased over 40% in the past year, investors should reassess their position as dividends could be impacted by future earnings changes.
Informational only, not financial advice. Content is AI-generated and may contain errors. How this works.
About Bristol-Myers Squibb Company (BMY)
Bristol Myers Squibb is a major pharmaceutical company focused on oncology and immunology.
The Health Care sector covers pharmaceutical, biotech, device and managed-care companies.
Earlier BMY news
- AstraZeneca and Bristol Myers Squibb Discuss Potential Merger
- Wall St Futures Rise 1.12% on Mideast Deal Hopes and Healthcare
- Stocks Making Moves Premarket: Alibaba, Bristol-Myers, eBay
- AstraZeneca to Discuss $400 Billion Merger with Bristol Myers Squibb
- BMY vs JNJ: Healthcare Revenue Comparison for 2025
Get the weekly market brief
One email every Monday: what moved, why, and what to watch. Free, unsubscribe anytime.
Get stories like this as they break
Our Telegram channel posts every market story the moment it is published. Free, and you can mute or leave anytime.



